The results suggest that the blood GLP-1 concentration may be a potential early indicator of MetS risk in women without a diagnosed disease, especially in those who are postmenopausal, and could serve as a helpful strategy for preventing the development of chronic degenerative diseases. Here, GCG is linked to metabolic syndrome.